Pharmigene, Inc. (7595.TWO)
TWD 13.8
(0.0%)
TWD 13.8
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 132.7 Million | 133.8 Million | 129.35 Million | 101.35 Million | 65.27 Million |
| Cost of Revenue | 90.16 Million | 89.07 Million | 83.3 Million | 57.06 Million | 43.19 Million |
| Gross Profit | 42.54 Million | 44.72 Million | 46.04 Million | 44.29 Million | 22.07 Million |
| Operating Expenses | 101.72 Million | 88.58 Million | 70.21 Million | 56.75 Million | 57.97 Million |
| Selling, General and Administrative Expenses | 71.38 Million | 58.89 Million | 54.73 Million | 48.03 Million | 40.64 Million |
| Research and Development Expenses | 30.33 Million | 29.69 Million | 15.48 Million | 8.71 Million | 12.08 Million |
| Other Expenses | - | 896 Thousand | 26 Thousand | 4.51 Million | - |
| Cost and Expenses | 191.89 Million | 177.66 Million | 153.52 Million | 113.81 Million | 101.17 Million |
| Operating Income | -59.18 Million | -42.4 Million | -24.9 Million | -7.73 Million | -30.64 Million |
| Interest Expense | 7.91 Million | 203 Thousand | 307 Thousand | 356 Thousand | 157 Thousand |
| Income Tax Expense | 16 Thousand | 11 Thousand | -337 Thousand | 1.71 Million | 214 Thousand |
| Earnings before Tax | -72.63 Million | -42.7 Million | -23.77 Million | -9.49 Million | -35.32 Million |
| Net Income | -72.64 Million | -42.71 Million | -23.43 Million | -11.2 Million | -35.1 Million |
| Earnings Per Share Basic | -1.60 | -0.98 | -0.54 | -0.33 | -1.60 |
| Earnings Per Share Diluted | -1.60 | -0.98 | -0.54 | -0.33 | -1.60 |
| Weighted Average Shares Outstanding | 45.47 Million | 43.46 Million | 43.46 Million | 33.83 Million | 21.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 45.47 Million | 43.46 Million | 43.46 Million | 33.83 Million | 21.94 Million |
| Gross Margin | 0.32 | 0.33 | 0.36 | 0.44 | 0.34 |
| EBIT Margin | -0.32 | -0.17 | -0.08 | 0.04 | -0.40 |
| Profit Margin | -0.55 | -0.32 | -0.18 | -0.11 | -0.54 |
| EBITDA | -41.85 Million | -22.01 Million | -6.83 Million | 2.82 Million | -25.46 Million |
| Earnings Before Tax Margin | -0.45 | -0.32 | -0.19 | -0.08 | -0.47 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 23.92 Million | 23.92 Million | 39.56 Million | 132.7 Million | 39.56 Million | 26.79 Million |
| Cost of Revenue | 14.78 Million | 14.78 Million | 27.71 Million | 90.16 Million | 27.71 Million | 17.36 Million |
| Gross Profit | 9.14 Million | 9.14 Million | 11.84 Million | 42.54 Million | 11.84 Million | 9.42 Million |
| Operating Expenses | 32.49 Million | 30.65 Million | 31.2 Million | 101.65 Million | 31.2 Million | 23.23 Million |
| Selling, General and Administrative Expenses | 25.36 Million | 25.36 Million | 19.61 Million | - | 19.61 Million | 16.07 Million |
| Research and Development Expenses | 7.13 Million | 7.13 Million | 7.75 Million | - | 7.75 Million | 7.41 Million |
| Other Expenses | - | - | - | 1.36 Million | - | - |
| Cost and Expenses | 47.27 Million | 45.43 Million | 58.91 Million | 191.82 Million | 58.91 Million | 40.6 Million |
| Operating Income | -23.34 Million | -23.34 Million | -15.51 Million | -60.89 Million | -15.51 Million | -14.07 Million |
| Interest Expense | - | - | - | 7.91 Million | - | - |
| Income Tax Expense | 17.5 Thousand | 17.5 Thousand | 500.00 | 16 Thousand | 500.00 | 7500.00 |
| Earnings before Tax | -24.32 Million | -24.32 Million | -21.98 Million | -72.63 Million | -21.98 Million | -14.32 Million |
| Net Income | -24.34 Million | -24.34 Million | -21.98 Million | -72.64 Million | -21.98 Million | -14.33 Million |
| Earnings Per Share Basic | -0.48 | -0.48 | -0.46 | - | -0.46 | -0.33 |
| Earnings Per Share Diluted | -0.48 | -0.48 | -0.46 | - | -0.46 | -0.33 |
| Weighted Average Shares Outstanding | 50.46 Million | 50.46 Million | 47.49 Million | 45.47 Million | 47.49 Million | 43.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 50.46 Million | 50.46 Million | 47.49 Million | 45.47 Million | 47.49 Million | 43.46 Million |
| Gross Margin | 0.38 | 0.38 | 0.30 | 0.32 | 0.30 | 0.35 |
| EBIT Margin | -0.78 | -0.78 | -0.27 | - | -0.27 | -0.41 |
| Profit Margin | -1.02 | -1.02 | -0.56 | -0.55 | -0.56 | -0.54 |
| EBITDA | -18.61 Million | -18.61 Million | -10.73 Million | - | -10.73 Million | -10.86 Million |
| Earnings Before Tax Margin | -0.98 | -0.98 | -0.39 | -0.46 | -0.39 | -0.53 |
603929
TPZEF
TNSE
600522
FBRT
2911